SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-19-008480
Filing Date
2019-07-01
Accepted
2019-07-01 16:22:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 neon2019s-3.htm S-3 632830
2 EXHIBIT 1.2 exhibit12-neon2019sx3salesag.htm EX-1.2 272877
3 EXHIBIT 4.3 exhibit43-neon2019sx3xform.htm EX-4.3 431837
4 EXHIBIT 4.4 exhibit44-neon2019sx3xform.htm EX-4.4 435150
5 EXHIBIT 5.1 exhibit51-neon2019sx3opini.htm EX-5.1 16817
6 EXHIBIT 5.2 exhibit52-neon2019sx3opini.htm EX-5.2 8907
7 EXHIBIT 23.1 exhibit231-neon2019sx3xcon.htm EX-23.1 2429
8 GRAPHIC neonlogo1a.jpg GRAPHIC 22177
9 GRAPHIC outsidefrontcover2a.jpg GRAPHIC 6647
  Complete submission text file 0001628280-19-008480.txt   1841840
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232487 | Film No.: 19933472
SIC: 2836 Biological Products, (No Diagnostic Substances)